Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5658)
All Articles published online
|
Publishing Process of This Article
|
Nov 27, 2021 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pal P, Palui R, Ray S. Heterogeneity of non-alcoholic fatty liver disease: Implications for clinical practice and research activity. World J Hepatol 2021; 13(11): 1584-1610 [PMID: 34904031 DOI: 10.4254/wjh.v13.i11.1584] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i11/1584.htm |
| Number | Citing Articles |
| 1 |
Xiulu Guan, Shiyuan Shen, Jinxia Liu, Hongru Song, Jinhua Chang, Xiaoxia Mao, Jingyu Song, Lin Zhang, Cuizhe Liu. Protective effects of baicalin magnesium on non-alcoholic steatohepatitis rats are based on inhibiting NLRP3/Caspase-1/IL-1β signaling pathway. BMC Complementary Medicine and Therapies 2023; 23(1) doi: 10.1186/s12906-023-03903-2
|
| 2 |
Kai En Chan, Tiffany Jia Ling Koh, Ansel Shao Pin Tang, Jingxuan Quek, Jie Ning Yong, Phoebe Tay, Darren Jun Hao Tan, Wen Hui Lim, Snow Yunni Lin, Daniel Huang, Mark Chan, Chin Meng Khoo, Nicholas W S Chew, Apichat Kaewdech, Naichaya Chamroonkul, Yock Young Dan, Mazen Noureddin, Mark Muthiah, Mohammed Eslam, Cheng Han Ng. Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals. The Journal of Clinical Endocrinology & Metabolism 2022; 107(9): 2691 doi: 10.1210/clinem/dgac321
|
| 3 |
Chengyuan Sun, Yan Guo, Peixu Cong, Yuan Tian, Xiang Gao. Liver Lipidomics Analysis Revealed the Novel Ameliorative Mechanisms of L-Carnitine on High-Fat Diet-Induced NAFLD Mice. Nutrients 2023; 15(6): 1359 doi: 10.3390/nu15061359
|
| 4 |
Amedeo Lonardo. Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review. Metabolism and Target Organ Damage 2024; 4(2) doi: 10.20517/mtod.2024.07
|
| 5 |
Carlos J Pirola, Silvia Sookoian. Advances in our understanding of the molecular heterogeneity of fatty liver disease: toward informed treatment decision making. Expert Review of Gastroenterology & Hepatology 2023; 17(4): 317 doi: 10.1080/17474124.2023.2191190
|
| 6 |
Ethan C. Z. Lee, Vickram V. Anand, Alex C. Razavi, Pamela L. Alebna, Mark D. Muthiah, Mohammad S. Siddiqui, Nicholas W. S. Chew, Anurag Mehta. The Global Epidemic of Metabolic Fatty Liver Disease. Current Cardiology Reports 2024; 26(4): 199 doi: 10.1007/s11886-024-02025-6
|
| 7 |
Hyun-Ju Park, Juyong Choi, Hyunmi Kim, Da-Yeon Yang, Tae Hyeon An, Eun-Woo Lee, Baek-Soo Han, Sang Chul Lee, Won Kon Kim, Kwang-Hee Bae, Kyoung-Jin Oh. Cellular heterogeneity and plasticity during NAFLD progression. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1221669
|
| 8 |
Kun-Lin Cheng, Shao-Wen Wang, Yu-Ming Cheng, Tsung-Han Hsieh, Chia-Chi Wang, Jia-Horng Kao. Prevalence and clinical outcomes in subtypes of metabolic associated fatty liver disease. Journal of the Formosan Medical Association 2024; 123(1): 36 doi: 10.1016/j.jfma.2023.07.010
|
| 9 |
Yu-Ming Cheng, Chia-Chi Wang, Jia-Horng Kao. Metabolic associated fatty liver disease better identifying patients at risk of liver and cardiovascular complications. Hepatology International 2023; 17(2): 350 doi: 10.1007/s12072-022-10449-x
|
| 10 |
Hsin-Tien Ho, Yu-Lueng Shih, Tien-Yu Huang, Wen-Hui Fang, Chang-Hsien Liu, Jung-Chun Lin, Chih-Weim Hsiang, Kai-Min Chu, Cheng-Huei Hsiong, Guan-Ju Chen, Yung-En Wu, Jia-Yu Hao, Chih-Wen Liang, Oliver Yoa-Pu Hu. Mixed active metabolites of the SNP-6 series of novel compounds mitigate metabolic dysfunction-associated steatohepatitis and fibrosis: promising results from pre-clinical and clinical trials. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05686-7
|
| 11 |
Marcin Kosmalski, Izabela Szymczak-Pajor, Józef Drzewoski, Agnieszka Śliwińska. Non-Alcoholic Fatty Liver Disease Is Associated with a Decreased Catalase (CAT) Level, CT Genotypes and the T Allele of the -262 C/T CAT Polymorphism. Cells 2023; 12(18): 2228 doi: 10.3390/cells12182228
|
| 12 |
Mirolyuba Ilieva, James Dao, Henry E. Miller, Jens Hedelund Madsen, Alexander J. R. Bishop, Sakari Kauppinen, Shizuka Uchida. Systematic Analysis of Long Non-Coding RNA Genes in Nonalcoholic Fatty Liver Disease. Non-Coding RNA 2022; 8(4): 56 doi: 10.3390/ncrna8040056
|
| 13 |
Kai En Chan, Cheng Han Ng, Clarissa Elysia Fu, Jingxuan Quek, Gwyneth Kong, Yi Jie Goh, Rebecca Wenling Zeng, Michael Tseng, Manik Aggarwal, Benjamin Nah, Douglas Chee, Zhen Yu Wong, Sitong Zhang, Jiong-Wei Wang, Nicholas W.S. Chew, Yock Young Dan, Mohammad Shadab Siddiqui, Mazen Noureddin, Arun J. Sanyal, Mark Muthiah. The Spectrum and Impact of Metabolic Dysfunction in MAFLD: A Longitudinal Cohort Analysis of 32,683 Overweight and Obese Individuals. Clinical Gastroenterology and Hepatology 2023; 21(10): 2560 doi: 10.1016/j.cgh.2022.09.028
|
| 14 |
Salah Abdalrazak Alshehade. Resmetirom's approval: Highlighting the need for comprehensive approaches in NASH therapeutics. Clinics and Research in Hepatology and Gastroenterology 2024; 48(7): 102377 doi: 10.1016/j.clinre.2024.102377
|
| 15 |
Costanza Renata Neri, Serena Scapaticci, Francesco Chiarelli, Cosimo Giannini. Liver Steatosis: A Marker of Metabolic Risk in Children. International Journal of Molecular Sciences 2022; 23(9): 4822 doi: 10.3390/ijms23094822
|
| 16 |
Nimish Thakral, Hailemichael Desalegn, Luis Antonio Diaz, Daniel Cabrera, Rohit Loomba, Marco Arrese, Juan Pablo Arab. A Precision Medicine Guided Approach to the Utilization of Biomarkers in MASLD. Seminars in Liver Disease 2024; 44(03): 273 doi: 10.1055/a-2364-2928
|
| 17 |
Fen Rong, Yiyi Mai, Lujia Shou, Xinya Zhu, Meiyue Li, Liuchen Zhu, Xiuli Sun, Xinhua Zhao. Analysis of the association between non-alcoholic fatty liver disease and mortality in United States adults. Frontiers in Nutrition 2024; 11 doi: 10.3389/fnut.2024.1502671
|
| 18 |
Tanvi Singla, Komal N Muneshwar, Aniket G Pathade, Seema Yelne. Hepatocytic Ballooning in Non-alcoholic Steatohepatitis: Bridging the Knowledge Gap and Charting Future Avenues. Cureus 2023; doi: 10.7759/cureus.45884
|
| 19 |
Mahdi Barazesh, Sajad Jalili, Morteza Akhzari, Fouzieyeh Faraji, Ebrahim Khorramdin. Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities,
and Management of Non-alcoholic Fatty Liver Disorder. Current Drug Therapy 2024; 19(1): 20 doi: 10.2174/1574885518666230417111247
|
| 20 |
Olufunto O. Badmus, Zachary A. Kipp, Evelyn A. Bates, Alexandre A. da Silva, Lucy C. Taylor, Genesee J. Martinez, Wang-Hsin Lee, Justin F. Creeden, Terry D. Hinds, David E. Stec. Loss of hepatic PPARα in mice causes hypertension and cardiovascular disease. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2023; 325(1): R81 doi: 10.1152/ajpregu.00057.2023
|
| 21 |
Yu-Ming Cheng, Shao-Wen Wang, Chia-Chi Wang, Jia-Horng Kao. Clinical characteristics of lean metabolic-associated fatty liver disease and the impact of concurrent diabetes mellitus. Tzu Chi Medical Journal 2024; 36(4): 425 doi: 10.4103/tcmj.tcmj_253_23
|
| 22 |
Line Ravndal, Katrine P. Lindvig, Ellen L. Jensen, Anita Sunde, Damoun Nassehi, Maja Thiele, Aleksander Krag, Svein Kjosavik. Algorithms for early detection of silent liver fibrosis in the primary care setting – a scoping review. Expert Review of Gastroenterology & Hepatology 2023; 17(10): 985 doi: 10.1080/17474124.2023.2255522
|
| 23 |
Helaina E. Huneault, Ana Ramirez Tovar, Cristian Sanchez-Torres, Jean A. Welsh, Miriam B. Vos. The Impact and Burden of Dietary Sugars on the Liver. Hepatology Communications 2023; 7(11) doi: 10.1097/HC9.0000000000000297
|
| 24 |
Nuria Perez-Diaz-del-Campo, Diego Martínez-Urbistondo, Elisabetta Bugianesi, J. Alfredo Martínez. Diagnostic scores and scales for appraising Nonalcoholic fatty liver disease and omics perspectives for precision medicine. Current Opinion in Clinical Nutrition & Metabolic Care 2022; 25(5): 285 doi: 10.1097/MCO.0000000000000849
|
| 25 |
Fahad Lakhdhir, Agha Syed Muhammad, Ahmed Nasir Qureshi, Imran A Shaikh, Imran Joher, Jawaria Majeed, Javaria Khan . Assessing Mortality Disparities Among Non-Alcoholic Fatty Liver Disease Metabolic Dysfunction Fatty Liver Disease and Metabolic Dysfunction-Associated Liver Disease: A Comprehensive Meta-Analysis. Cureus 2024; doi: 10.7759/cureus.71639
|
| 26 |
Gino A. Kurian, Bhavana Sivakumar. Phospholipases in Physiology and Pathology. 2023; : 3 doi: 10.1016/B978-0-443-15177-4.00007-8
|